We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) Oxybutynin hydrochloride 5mg tablets (Niche Generics Limited)
Section 19A approved medicine
(Approval lapsed) Oxybutynin hydrochloride 5mg tablets (Niche Generics Limited)
Section 19A approval holder
Orspec Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Expired
Medicines in short supply/unavailable
DITROPAN oxybutynin hydrochloride 5mg tablet bottle AUST R: 48965
Indication(s)
Treatment of detrusor over-activity where conservative measures have failed.
Images
